Titre : | Addiction, vol. 106, n°7, juillet 2011 |
Année de publication : | 2011 |
Mots-clés : |
SANTEPSY ACCIDENT ; AMPHETAMINE ; ANALYSE CHIMIQUE ; ANGOISSE PRIMITIVE ; AUDIT ; CANNABIS ; COCAINE ; COMPARAISON ; CONDUITE DE VEHICULE ; CONSULTATION ; DEPENDANCE ; DEPISTAGE ; ECHELLE D'EVALUATION ; ECSTASY ; EFFICACITE ; ENFANT D'USAGER ; EPIDEMIOLOGIE DESCRIPTIVE ; ETHYLOTEST ; ETUDE LONGITUDINALE ; ETUDE TRANSVERSALE ; EVOLUTION ; FACTEUR PREDICTIF ; FUMEUR ; INTERDICTION DE FUMER ; LEGISLATION ; MEDECIN ; MESURES QUANTITATIVES ; MODELE ; OBLIGATION DE SOINS ; OPIACES ; PERSONNEL MEDICAL ; PERSONNEL PARAMEDICAL ; PREVALENCE ; PREVENTION ; PRODUIT ILLICITE ; PROGRAMME ; QUESTIONNAIRE ; RECHERCHE QUALITATIVE ; RECOMMANDATION ; REGLEMENTATION ; RELATION PARENT ENFANT ; REPRESENTATION SOCIALE ; SANCTION PENALE ; SOCIALISATION ; SYNDROME DE SEVRAGE ; TABAC ; TEST ; TRANSPORT AERIEN ; USAGE ; USAGE RECREATIF |
Résumé : |
CONTENTS Alcohol harm - the urgent need for a global response. Casswell S., p. 1205-1207. Can food be addictive? Public health and policy implications. Gearhardt A.N., Grilo C.M., Dileone R.J., Brownell K.D., Potenza M.N., p. 1208-1212. Obesity - is food addiction to blame? Rogers P.J., p. 1213-1214. Food and addiction - sugars, fats and hedonic overeating. Avena N.M., Gold M.S., p. 1214-1215. Maternal diet and offspring development. Davis C., p. 1215-1216. Food addiction not helpful: the hedonic component - implicit wanting - is important. Blundell J.E., Finlayson G., p. 1216-1218. All foods are habit-forming - what I want to know is which will kill me! Smith T.G., p. 1218-1219. Important next steps in evaluating food's addictive potential. Gearhardt A.N., Dileone R.J., Grilo C.M., Brownell K.D., Potenza M.N., p. 1219-1220. Towards a national model for managing impaired driving offenders. Voas R.B., Dupont R.L., Talpins S.K., Shea C.L., p. 1221-1227. Commentary on Voas et al. (2011): Drug-free roadways - can we get there from here? Steps to reducing drugged driving in the United States. Gil Kerlikowske R., Sabet K., p. 1228-1229. Measuring alcohol craving: development of the Alcohol Craving Experience questionnaire. Statham D.J., Connor J.P., Kavanagh D.J., Feeney G.F., Young R.M., May J., et al., p. 1230-1238. Alcohol-related discussions in health care-a population view. Makela P., Havio M., Seppa K., p. 1239-1248. Commentary on Makelaet al. (2011): How many patients must be asked about alcohol before it is enough? Spak F., p. 1249-1250. The prevalence of alcohol use disorders among night-time weekend drivers. Furr-Holden C.D., Voas R.B., Lacey J., Romano E., Jones K., p. 1251-1260. Does readiness to change predict in-session motivational language? Correspondence between two conceptualizations of client motivation. Hallgren K.A., Moyers T.B., p. 1261-1269. Associations between drinking motives and changes in adolescents' alcohol consumption: a full cross-lagged panel study. Schelleman-Offermans K., Kuntsche E., Knibbe R.A., p. 1270-1278. Effects of major depression on crack use and arrests among women in drug court. Johnson J.E., O'Leary C.C., Striley C.W., Abdallah A.B., Bradford S., Cottler L.B., p. 1279-1286. Drug violations and aviation accidents: findings from the US mandatory drug testing programs. Li G., Baker S.P., Zhao Q., Brady J.E., Lang B.H., Rebok G.W., et al., p. 1287-1292. Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users. Morefield K.M., Keane M., Felgate P., White J.M., Irvine R.J., p. 1293-1300. Deviant socialization mediates transmissible and contextual risk on cannabis use disorder development: a prospective study. Tarter R.E., Fishbein D., Kirisci L., Mezzich A., Ridenour T., Vanyukov M., p. 1301-1308. Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial. Everly J.J., Defulio A., Koffarnus M.N., Leoutsakos J.M., Donlin W.D., Aklin W.M., et al., p. 1309-1318. Prescribing of smoking cessation medication in England since the introduction of varenicline. Langley T.E., Huang Y., McNeill A., Coleman T., Szatkowski L., Lewis S., p. 1319-1324. Relative performance of common biochemical indicators in detecting cigarette smoking. Marrone G.F., Shakleya D.M., Scheidweiler K.B., Singleton E.G., Huestis M.A., Heishman S.J., p. 1325-1334. Prospective predictors of quitting behaviours among adult smokers in six cities in China: findings from the International Tobacco Control (ITC) China Survey. Li L., Feng G., Jiang Y., Yong H.H., Borland R., Fong G.T., p. 1335-1345. Does the introduction of comprehensive smoke-free legislation lead to a decrease in population smoking prevalence? Bajoga U., Lewis S., McNeill A., Szatkowski L., p. 1346-1354. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Unger A., Jagsch R., Jones H., Arria A., Leitich H., Rohrmeister K., et al., p. 1355-1362. Bruce rounsaville (1949-2011). Carroll K.M., p. 1363-1364. Residual neurocognitive features of ecstasy use: a re-interpretation of halpern et al. (2011) consistent with serotonergic neurotoxicity. Parrott A.C., p. 1365-1268. Comment on halpern et al. (2011). Fisk J.E., Murphy P.N., Montgomery C., Wareing M., p. 1368-1369. 'Ecstasy use, by itself, does not result in residual neurotoxicity'- a powerful argument? Rodgers J., Buchanan T., Heffernan T., Ling J., Scholey A., p. 1369-1370. Reply to parrott (2011), fisk et al. (2011) and rodgers et al. (2011). Halpern J.H., Sherwood A.R., Hudson J.I., Gruber S., Kozin D., Pope H.G., Jr., p. 1370-1372. |
Exemplaires (1)
Localisation | Cote | Emplacement | Support | Section | Disponibilité |
---|---|---|---|---|---|
Hôpital Marmottan | Abonnement | Hôpital Marmottan | Périodique | Généralités | Disponible |